Participants 31 89 4
thrombocytopenic subjects with hepatitis C virus infection
Participants 257 490 7
Demographic, clinical and genetic data collected from thrombocytopenic patients (n = 1463, age ≥ 18 years) with chronic HCV infection who were able to achieve a target platelet count of > 90 × 10(9) /L following eltrombopag treatm
